A Study to Evaluate the Efficacy and Safety of JS002 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH).
Clinical trial NCT05325203 · COMPLETED
Trial details
- NCT number
- NCT05325203
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2023-05-08
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.